Oramed Pharmaceuticals ORMP Estimates

NASDAQ ORMP
$4.69 -0.06 (-1.26%)
At close: Sep 29, 2026 · 4:00 PM EDT
Analyst Estimates

Oramed Pharmaceuticals Inc. Revenue Estimates

Periods 18
Next Period Q2 25
Consensus 0.00

Analysts expect Oramed Pharmaceuticals Inc. to report revenue of 0.00 for Q2 25, against a range of 0.00 to 0.00. The most recent reported quarter, Q2 26, came in at 0.00.

Metric Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27Q1 28Q2 28Q3 28Q4 28
Reported (Actual) 0.000.002.00 M--0.000.000.00------
High Estimate 0.000.000.000.000.000.00-0.000.000.00158,762.79-212,388.261,017.92109,200.66
Low Estimate 0.000.000.000.000.000.00-0.000.000.00149,236.07-243,542.96895.4896,238.28
Consensus Estimate 0.000.000.000.000.000.00-0.000.000.00153,999.43-227,965.61956.70102,719.47
Analyst Estimates

Oramed Pharmaceuticals Inc. Earnings Per Share (EPS) Estimates

Periods 18
Next Period Q3 26
Consensus 0.46

Analysts expect Oramed Pharmaceuticals Inc. to report earnings per share of 0.46 for Q3 26, against a range of 0.43 to 0.49. The most recent reported quarter, Q2 26, came in at 2.76, a 500.0% beat against the 0.46 consensus.

Metric Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27Q1 28Q2 28Q3 28Q4 28
Reported (Actual) -0.48-0.25-0.190.321.160.000.912.76--------
High Estimate 0.01-0.02-0.01-0.04-0.04-0.06-0.500.490.38-0.411.37-0.64-0.930.183.37
Low Estimate 0.01-0.02-0.01-0.04-0.04-0.08-0.420.430.32-0.451.17-0.70-1.130.162.83
Consensus Estimate 0.01-0.02-0.01-0.04-0.04-0.07-0.460.460.35-0.431.27-0.67-1.030.173.10

Oramed Pharmaceuticals Inc. Estimates API

Pull Wall Street consensus for Oramed Pharmaceuticals Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/estimates?ticker=ORMP&mode=revenue&api_key=YOUR_API_KEY